1. Home
  2. STGW vs AUPH Comparison

STGW vs AUPH Comparison

Compare STGW & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$8.25

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.39

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
AUPH
Founded
1980
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
STGW
AUPH
Price
$8.25
$16.39
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$8.39
★ $17.25
AVG Volume (30 Days)
★ 961.4K
733.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 5075.00
EPS
N/A
★ 0.53
Revenue
★ $2,909,000,000.00
$283,055,000.00
Revenue This Year
$13.27
$17.54
Revenue Next Year
$4.07
$15.74
P/E Ratio
★ N/A
$31.05
Revenue Growth
2.39
★ 20.38
52 Week Low
$4.29
$10.92
52 Week High
$9.55
$19.25

Technical Indicators

Market Signals
Indicator
STGW
AUPH
Relative Strength Index (RSI) 43.96 50.90
Support Level $8.05 $15.65
Resistance Level $9.55 $16.40
Average True Range (ATR) 0.25 0.41
MACD -0.04 -0.03
Stochastic Oscillator 28.21 41.61

Price Performance

Historical Comparison
STGW
AUPH

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: